# Neratinib

## Nerlynx 40 mg (180 tablets/bot)

##### 臨採

| 標題       | 說明                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|:-----------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 藥品代碼   | ONER                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 適應症     | Breast cancer, Extended adjuvant, early stage, HER2-positive, following adjuvant trastuzumab based therapy.                                                                                                                                                                                                                                                                                                                                                                                                               |
| 用法用量   | No Data                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 肝功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 禁忌       | None.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 副作用     | Common Dermatologic: Rash (18% ) Endocrine metabolic: Weight decreased (5% to 20% ) Gastrointestinal: Abdominal pain (36% ), Constipation (31% ), Decrease in appetite (12% to 35% ), Diarrhea (78% to 98% ), Indigestion (10% ), Nausea (43% to 53% ), Stomatitis (14% ), Vomiting (26% to 46% ) Hepatic: ALT/SGPT level raised (9% ), Aspartate aminotransferase serum level raised (7% ) Musculoskeletal: Spasm (11% ) Neurologic: Dizziness (14% ) Other: Fatigue (27% to 45% ) Serious Renal: Renal impairment (7% ) |
| 孕期建議   | Uknown 沒有資料                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 哺乳期建議 | Unknown 沒有資料                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |

